These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10417175)

  • 1. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.
    Ausiello CM; Lande R; Urbani F; la Sala A; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
    Infect Immun; 1999 Aug; 67(8):4064-71. PubMed ID: 10417175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.
    Ausiello CM; Urbani F; la Sala A; Lande R; Cassone A
    Infect Immun; 1997 Jun; 65(6):2168-74. PubMed ID: 9169747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.
    Cassone A; Ausiello CM; Urbani F; Lande R; Giuliano M; La Sala A; Piscitelli A; Salmaso S
    Arch Pediatr Adolesc Med; 1997 Mar; 151(3):283-9. PubMed ID: 9080938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children.
    Tran Minh NN; Edelman K; He Q; Viljanen MK; Arvilommi H; Mertsola J
    Vaccine; 1998 Oct; 16(17):1604-10. PubMed ID: 9713935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
    Fadugba OO; Wang L; Chen Q; Halasa NB
    Clin Vaccine Immunol; 2014 Dec; 21(12):1613-9. PubMed ID: 25253666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.
    Cherry JD; Heininger U; Richards DM; Storsaeter J; Gustafsson L; Ljungman M; Hallander HO
    Clin Vaccine Immunol; 2010 May; 17(5):741-7. PubMed ID: 20335431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.
    Annunziato PW; Rothstein EP; Bernstein HH; Blatter MM; Reisinger KS; Pichichero ME
    Arch Pediatr Adolesc Med; 1994 May; 148(5):503-7. PubMed ID: 8180641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
    Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
    J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.
    Huang LM; Lee CY; Lin TY; Chen JM; Lee PI; Hsu CY
    Vaccine; 1996 Jun; 14(9):916-22. PubMed ID: 8843635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
    Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.
    Edelman KJ; He Q; Makinen JP; Haanpera MS; Tran Minh NN; Schuerman L; Wolter J; Mertsola JA
    Clin Infect Dis; 2004 Jul; 39(2):179-85. PubMed ID: 15307026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults.
    Tran Minh NN; He Q; Edelman K; Putto-Laurila A; Arvilommi H; Viljanen MK; Mertsola J
    Vaccine; 2000 Apr; 18(19):1971-4. PubMed ID: 10706957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.
    Rieber N; Graf A; Belohradsky BH; Hartl D; Urschel S; Riffelmann M; Wirsing von König CH; Liese J
    Vaccine; 2008 Dec; 26(52):6929-35. PubMed ID: 18852002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.